2019
DOI: 10.1016/j.compbiolchem.2018.12.022
|View full text |Cite
|
Sign up to set email alerts
|

Identifying condition specific key genes from basal-like breast cancer gene expression data

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 22 publications
0
4
0
Order By: Relevance
“…The methylation levels of the ZNF215 gene and the PTGS2 gene were negatively correlated with their expression levels. Furthermore, the ZNF215 gene can be used as a diagnostic and prognostic biomarker for basal-like breast cancer and acute myeloid leukemia ( 42 , 43 ). Among them, the view that S. saccharolyticus can further promote the proliferation and cloning of gastric cells by regulating the gene expression level of ZNF215 has been verified by cell experiments in this paper, which increased the reliability of our data analysis results.…”
Section: Discussionmentioning
confidence: 99%
“…The methylation levels of the ZNF215 gene and the PTGS2 gene were negatively correlated with their expression levels. Furthermore, the ZNF215 gene can be used as a diagnostic and prognostic biomarker for basal-like breast cancer and acute myeloid leukemia ( 42 , 43 ). Among them, the view that S. saccharolyticus can further promote the proliferation and cloning of gastric cells by regulating the gene expression level of ZNF215 has been verified by cell experiments in this paper, which increased the reliability of our data analysis results.…”
Section: Discussionmentioning
confidence: 99%
“…an independent prognostic biomarker in prostate cancer (Angulo et al, 2016) and Maind and Raut (2019) reported its expression as a diagnostic and prognostic biomarker of basal-like breast cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, its expression was associated with poor outcomes in hepatocellular carcinoma (HCC) and pancreatic ductal adenocarcinoma (Li et al, 2019). The hypermethylation of ZNF215 has been found an independent prognostic biomarker in prostate cancer (Angulo et al, 2016) and Maind and Raut (2019) reported its expression as a diagnostic and prognostic biomarker of basal‐like breast cancer. Additionally, loss of ZNF215 imprinting has been also associated with poor 5‐year survival (Yang et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…More specifically in gene expression data, discriminative patterns play an essential role to discover outcome-specific regulatory modules for knowledge acquisition, biomarking phenotypes of interest [ 7 ], or serve as the basis for drug targeting (e.g. cancer) after rigorous validation [ 8 ]. Discriminative pattern mining also plays a role in unraveling complex interactions in biological processes such as the condition-specific interplay among transcription factors in organisms [ 9 ].…”
Section: Introductionmentioning
confidence: 99%